• 1612 Citations
  • 13 h-Index
20092018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 5 Similar Profiles
Colorectal Neoplasms Medicine & Life Sciences
Medicare Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Dipeptidyl-Peptidase IV Inhibitors Medicine & Life Sciences
Hepatocellular Carcinoma Medicine & Life Sciences
Incidence Medicine & Life Sciences
Confidence Intervals Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2015 2015

Neoplasms
oxaliplatin
Therapeutics
Randomized Controlled Trials
Adjuvant Chemotherapy

Research Output 2009 2018

  • 1612 Citations
  • 13 h-Index
  • 37 Article
  • 3 Letter
  • 2 Review article
  • 1 Comment/debate
Dipeptidyl-Peptidase IV Inhibitors
Hypoglycemic Agents
Thiazolidinediones
Heart Failure
Propensity Score
3 Citations
pioglitazone
Dipeptidyl-Peptidase IV Inhibitors
Urinary Bladder Neoplasms
Type 2 Diabetes Mellitus
Safety
Survivors
Comorbidity
Young Adult
Survival Rate
Neoplasms

Impact of 5α-reductase inhibitor and α-blocker therapy for benign prostatic hyperplasia on prostate cancer incidence and mortality

Van Rompay, M. I., Curtis Nickel, J., Ranganathan, G., Kantoff, P. W., Solomon, K. R., Lund, J. LEIGH. & McKinlay, J. B., Jan 1 2018, (Accepted/In press) In : BJU international.

Research output: Contribution to journalArticle

Pharmacoepidemiology
Finasteride
Adrenergic alpha-Antagonists
Prostatic Hyperplasia
Prostatic Neoplasms
2 Citations

Patient-Reported Comorbidity and Survival in Older Adults with Cancer

Williams, G. R., Deal, A. M., Lund, J. LEIGH., Chang, Y. K., Muss, H. B., Pergolotti, M., Guerard, E. J., Shachar, S. S., Wang, Y., Kenzik, K. & Sanoff, H., Apr 1 2018, In : Oncologist. 23, 4, p. 433-439 7 p.

Research output: Contribution to journalArticle

Comorbidity
Survival
Neoplasms
Mortality
Clinical Trials